SINGAPORE (Oct 2): Vensica Medical, a portfolio company of The Trendlines Group, has received a US$2 million ($2.7 million) investment from NASDAQ-listed Cogentix Medical.

Following the investment, Trendlines will see its effective interest in Vensica fall from 33.58% to 26.87%, on a fully diluted basis.

In addition, Cogentix has signed for options to acquire the entire equity stake in Vensica for an additional US$8 million, if business and clinical milestones are achieved.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook